Zurich Extends Regulated Cannabis Pilot Program Through 2028 After Positive Results
Zurich has extended its regulated cannabis pilot program through October 2028, citing robust data and ongoing efforts to inform potential national legalization in Switzerland
Key Points
- 1Zurich extended its regulated cannabis pilot program for two more years, now running through October 2028
- 2The program involves 2,456 registered users and 21 access points, with 110,500 sales and 940 kg of cannabis distributed
- 3Swiss officials aim to gather real-world data on consumption, public health, and the illicit market before national legalization debates
- 4The study compares three different distribution models to determine the most effective approach
- 5Switzerland's evidence-based pilot puts it among the leading European countries in cannabis reform
Zurich has reaffirmed its leadership in European cannabis reform by extending its regulated cannabis pilot program for another two years, pushing the end date to October 2028. The move follows a government vote in March and is driven by strong, consistent data emerging from the initiative, according to High Times. The Züri Can – Cannabis with Responsibility program was designed to analyze how access to legal cannabis within a tightly regulated system affects consumer behavior and public health outcomes
Switzerland, while still prohibiting general adult-use cannabis sales, has adopted a pragmatic approach by authorizing scientific pilot programs in several cities. Zurich's pilot, one of the most closely watched in Europe, allows nearly 2,500 registered participants to purchase regulated cannabis products through 21 access points. Products are grown under strict regulatory standards and typically sold in 5-gram packages, with 110,500 transactions and 940 kilograms distributed so far
Officials are keen to ensure that policy is informed by real-world data, not assumptions. Andreas Hauri, Zurich’s Director of Health, emphasized this pragmatic stance: “Thousands of people consume cannabis in Zurich. We must acknowledge this reality and act accordingly.” The program also compares three different distribution models, aiming to identify the most effective and safe system for potential national legalization
The Swiss Federal Office of Public Health underscored the evidence-based approach, stating, “The scientific findings emerging from the study will form the basis for discussions concerning an evidence-based and practical future implementation of a responsible cannabis policy in Switzerland.” Alongside other reform-minded countries like Germany and the Netherlands, Switzerland is moving faster than much of Europe in experimenting with regulated cannabis access
From the OG Lab newsroom perspective, Zurich’s extension of its pilot program signals growing momentum for evidence-driven cannabis policy in Europe. If the data continues to show reduced illicit market activity, stable usage, and public health benefits, Switzerland could become a model for national legalization strategies across the region. This is a development to watch closely as the continent’s regulatory landscape evolves
